Learn more about whether Glaukos Corporation or PROCEPT BioRobotics Corporation is a better investment based on AAII's A+ ...

Learn more about whether iRhythm Technologies, Inc. or PROCEPT BioRobotics Corporation is a better investment based on AAII's ...

William Blair analyst Brandon Vazquez maintained a Buy rating on PROCEPT BioRobotics (PRCT – Research Report) today. The company’s shares ...

PROCEPT BioRobotics (PRCT) announced its Aquablation therapy was evaluated in the independent, investigator-initiated WATER III trial. This ...

Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT – Get Free Report) have been given a consensus rating of “Moderate Buy” by the ...

PROCEPT BioRobotics announced positive WATER III trial results for Aquablation therapy in large prostates, showing effective outcomes and reduced complications. PROCEPT BioRobotics Corporation ...

Amundi increased its stake in PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) by 0.9% in the fourth quarter, according to ...

SAN JOSE, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing ...

SAN JOSE, Calif. - PROCEPT BioRobotics Corporation (NASDAQ:PRCT), a $3.18 billion market cap company specializing in surgical robotics, announced today that its Aquablation therapy has shown ...

"Watching our approach smoothly blend into current rehab protocols really strengthens our belief that it can revolutionize ...

The Aquablation water-based surgical procedure is safe and effective for use with enlarged prostates compared with laser ...

Baseline symptom scores decreased by 11-12 points at 3 months with aquablation and transurethral laser enucleation of the ...